Tumor-derived EVs/Exs are internalized by APCs, processed and cross-presented to cytotoxic CD8+ T cells, and vaccination of mice with tumor-derived EVs/Exs induces a potent CD8+ T cell–mediated anti-tumor response against not only the parental tumor, but also other tumors expressing similar tumor antigens [29]. This evidence concerns the gene CD8A and neoplasm.